94
VOLUME 11 NUMBER 2 • JUNE 2014
REVIEW
SA JOURNAL OF DIABETES & VASCULAR DISEASE
100. Gorman D, Sochett E, Daneman D. The natural history of microalbuminuria in
adolescents with type 1 diabetes.
J Pediatr
1999;
134
: 333–337.
101. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study
of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic
retinopathy and associated risk factors in type 1 diabetes.
Ophthalmology
1998;
105
: 1801–1815.
102. Kubin M, Tossavainen P, Hannula V,
et al.
Prevalence of retinopathy in Finnish
children and adolescents with type 1 diabetes: a cross-sectional population-based
retrospective study.
Arch Dis Child
2011;
96
: 963–968.
103. Barkai L, Kempler P, Vamosi I,
et al
. Peripheral sensory nerve dysfunction in
children and adolescents with type 1 diabetes mellitus.
Diabet Med
1998,
15
:
228–233.
104. Hyllienmark L, Brismar T, Ludvigsson J: Subclinical nerve dysfunction in children
and adolescents with IDDM.
Diabetologia
1995;
38
: 685–692.
105. Lee SS, Han HS, Kim H: A 5-yr follow-up nerve conduction study for the detection
of subclinical diabetic neuropathy in children with newly diagnosed insulin-
dependent diabetes mellitus.
Pediatr Diabetes
2010;
11
: 521–528.
106. Riihimaa PH, Suominen K, Tolonen U,
et al
.: Peripheral nerve function is increasingly
impaired during puberty in adolescents with type 1 diabetes.
Diabetes Care
2001;
24
: 1087–1092.
107. Solders G, Thalme B, Aguirre-Aquino M,
et al
. Nerve conduction and autonomic
nerve function in diabetic children. A 10-year follow-up study.
Acta Paediatr
1997;
86
: 361–366.
108. Craig ME, Handelsman P, Donaghue KC, et al. Predictors of glycaemic control and
hypoglycaemia in children and adolescents with type 1 diabetes from NSW and
the
ACT. Med J Aust
2002;
177
: 235–238.
109. Vanelli M, Chiarelli F, Chiari G, Tumini S. Relationship between metabolic control
and quality of life in adolescents with type 1 diabetes. Report from two Italian
centres for the management of diabetes in childhood.
Acta Biomed
2003;
74
(Suppl 1): 13–17.
110. Holl RW, Swift PG, Mortensen HB,
et al.
Insulin injection regimens and metabolic
control in an international survey of adolescents with type 1 diabetes over 3
years: results from the Hvidore study group.
Eur J Pediatr
2003;
162
: 22–29.
111. Hari Kumar KV, Shaikh A, Prusty P. Addition of exenatide or sitagliptin to insulin
in new onset type 1 diabetes: A randomized, open label study.
Diabetes Res Clin
Pract
2013. doi:
10
.1016/j.diabres.2013.1001.1020.
112. Ceriello A, Novials A, Ortega E,
et al
. Glucagon-like peptide 1 reduces endothelial
dysfunction, inflammation, and oxidative stress induced by both hyperglycemia
and hypoglycemia in type 1 diabetes.
Diabetes Care
2013;
36
(8): 2346–2350.
113. Klein R, Klein BE, Moss SE. The Wisconsin epidemiological study of diabetic
retinopathy: a review.
Diabetes Metab Rev
1989;
5
: 559–570.
114. van Hecke MV, Dekker JM, Stehouwer CD,
et al
. Diabetic retinopathy is associated
with mortality and cardiovascular disease incidence: the EURODIAB prospective
complications study.
Diabetes Care
2005;
28
: 1383–1389.
115. Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and
overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective
observational study.
Diabetes Care
2002;
25
: 859–864.
116. Wajchenberg BL, Feitosa AC, Rassi N, Lerario AC, Betti RT. Glycemia and
cardiovascular disease in type 1 diabetes mellitus.
Endocr Pract
2008;
14
: 912–
923.
117. American Diabetes Association. Hypertension management in adults with
diabetes.
Diabetes Care
2004;
27
: s65–s67.
118. NICE. Hypertension. The clinical management of primary hypertension in adults.
NICE Clinical Guideline 127. 2011. Available at
hypertension-cg127
webcite
[last accessed: 02-07-2013]. 2011.
119. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in
insulin dependent diabetes: 10 year observational follow up study.
Br Med J
1996;
313
: 779–784.
120. Cook J, Daneman D, Spino M,
et al
. Angiotensin converting enzyme inhibitor
therapy to decrease microalbuminuria in normotensive children with insulin-
dependent diabetes mellitus.
J Pediatr
1990;
117
: 39–45. The fourth report on
the diagnosis, evaluation, and treatment of high blood pressure in children and
adolescents
Pediatrics
2004;
114
: 555–576.
121. Couper JJ, Staples AJ, Cocciolone R,
et al.
Relationship of smoking and albuminuria
in children with insulin-dependent diabetes.
Diabet Med
1994;
11
: 666–669.
122. Astrup AS, Tarnow L, Rossing P,
et al.
Improved prognosis in type 1 diabetic
patients with nephropathy: a prospective follow-up study.
Kidney Int
2005;
68:
1250–1257.
90. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship
between mood and glycemic control.
J Diabetes Complications
2005;
19
:
113–122.
91. Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline.
J Neural
Transm
2003;
110
: 95–110.
92. Witte AV, Fobker M, Gellner R, Knecht S, Flöel A. Caloric restriction improves
memory in elderly humans. Proc Natl Acad Sci USA 2009; 106: 1255–1260.
93. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-
sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a
meta-analysis.
Diabetes Care
2010;
33
: 2477–2483.
94. Hu EA, Pan A, Malik V, Sun Q. White rice consumption and risk of type 2
diabetes: meta-analysis and systematic review.
Br Med J
(Clinical research ed.)
2012;
344
: e1454.
95. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, Lancet Physical
Activity Series Working Group. Effect of physical inactivity on major non-
communicable diseases worldwide: an analysis of burden of disease and life
expectancy.
Lancet
2012;
380
: 219–229.
96. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA,
et al
.
Association of systolic blood pressure with macrovascular and microvascular
complications of type 2 diabetes (UKPDS 36): prospective observational study.
Br Med J
2000;
321
: 412–419.
97. Risérus U, Willet W. Dietary fats and prevention of type 2 diabetes.
Prog Lipid
Res
2009;
48
: 44–51.
98. National Institute for Health and Clinical Excellence. Clinical guideline 66:
Type 2 diabetes. London, 2008.
99. Kahler W, Kuklinski B, Ruhlmann C. Diabetes mellitus – a free radical associated
disease. Results of adjuvant antioxidant supplementation.
Z Gesamte Inn Med
1993;
48
: 223–232.
Continued from page 86
